Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 135.00
Bid: 130.00
Ask: 140.00
Change: 0.00 (0.00%)
Spread: 10.00 (7.692%)
Open: 135.00
High: 135.00
Low: 135.00
Prev. Close: 135.00
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRT joins £37.8m LANDOne project with Airbus & ATI

30 Apr 2024 07:00

RNS Number : 4882M
Transense Technologies PLC
30 April 2024
 

Transense Technologies plc

 ("Transense" or the "Company")

 

Transense secures role in project developing next generation aircraft landing gear with Airbus

 

Transense Technologies plc, is pleased to announce that it has formally joined an Aerospace Technology Institute supported project, "LANDOne", with Airbus to provide SAWsense technology and support the development of next generation landing-systems technology.

 

LANDOne is a £37.8 Million project looking into new lighter, lower maintenance landing gear systems. Officially launched in 2022, Transense has joined the project due to the SAWsense technology potentially allowing critical measurements to be made that were not possible with other technologies.

 

Ryan Maughan, Managing Director of Transense said: "We are delighted to announce this new project with Airbus, building on our experience in the aerospace sector, and using SAWsense technology in an entirely new application for landing-systems. As well as developing cutting edge technology in this exciting application, the project allows Transense to build a relationship with world leading aerospace businesses."

 

The LANDOne project is part-funded by the Aerospace Technology Institute (ATI) Programme; a partnership between the ATI, the Government's Department for Business & Trade and Innovate UK (part of UK Research and Innovation). The ATI Programme provides funding for research & technology projects that maintain and grow the UK's competitive position in civil aerospace.

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Stefano Aquilino / Tony Quirke (Sales & Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper/Nick Rome/Joe Walker

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

 

Notes to Editors:

 

Transense is a developer of specialist sensor technology and measurement systems. The Company has two active business divisions:

 

· SAWsense, developing Surface Acoustic Wave (SAW) sensor technology, to improve performance, reliability and efficiency in focus markets of aerospace, automotive, robotics and industrial machinery; and

· Translogik a range of smart, connected tyre inspection and management equipment, used by leading tyre manufacturers, dealers and fleet operators to reduce costs and improve safety.

 

In addition, the Company earns residual royalty income from iTrack, a tyre condition and performance monitoring system, that was licenced to Bridgestone Corporation for a ten year period in 2020, expiring in 2030.

 

The Group's strategy is to deliver shareholder value through the delivery of sustainable revenue growth from its business divisions. Transense is successfully commercialising its IP and know-how, supporting its customers to develop applications for its key technologies, generating revenues through licensing, the supply of engineering services and product hardware.

 

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com

 

For further information please contact transense@walbrookpr.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUGCCUPCGMB
Date   Source Headline
6th Mar 200911:18 amRNSNotice of Preliminary Results
4th Feb 20095:00 pmRNSDirector/PDMR Shareholding
2nd Feb 20092:50 pmRNSGrant of Options
30th Jan 20092:37 pmRNSDirectorate Change
30th Jan 20091:47 pmRNSContract Win
12th Jan 20091:12 pmRNSHolding(s) in Company
22nd Dec 20083:33 pmRNSWaiver & Grant of New Options
12th Nov 200811:50 amRNSUpdate re Vectron International
21st Oct 20082:17 pmRNSHolding(s) in Company
20th Oct 200812:52 pmRNSDirector/PDMR Shareholding
17th Oct 20087:30 amRNSResponse to share price movement
13th Oct 200810:04 amRNSHolding(s) in Company
9th Oct 200810:09 amRNSHolding(s) in Company
19th Sep 200812:07 pmRNSHolding(s) in Company
16th Sep 20082:52 pmRNSDirector/PDMR Shareholding
4th Sep 20087:00 amRNSInterim Results
29th Aug 20083:45 pmRNSNotice of Results
26th Aug 20083:58 pmRNSHolding(s) in Company
30th Jul 200812:01 pmRNSHolding(s) in Company
29th Jul 20082:29 pmRNSHolding(s) in Company
15th Jul 20082:00 pmRNSRe Agreement
25th Jun 20087:00 amRNSDirector/PDMR Shareholding
2nd Jun 20087:19 amRNSDirectorate Change
15th Apr 20082:58 pmRNSDirector/PDMR Shareholding
15th Apr 200812:46 pmRNSPreliminary Results
10th Apr 20089:05 amRNSNotice of Results
4th Apr 20083:49 pmRNSHolding(s) in Company
3rd Apr 200812:47 pmRNSDirectorate Change
20th Mar 20084:24 pmRNSHolding(s) in Company
20th Mar 20084:19 pmRNSHolding(s) in Company-Amend
19th Mar 20084:00 pmRNSTotal Voting Rights
18th Mar 20082:49 pmRNSHolding(s) in Company
11th Mar 20085:43 pmRNSDirector Details
25th Feb 20082:41 pmRNSHolding(s) in Company
8th Feb 20087:30 amRNSDirector Declaration
8th Feb 20087:00 amRNSBoard and Adviser Change
16th Jan 20082:47 pmRNSHolding(s) in Company
4th Jan 200812:08 pmRNSResult of General Meeting
13th Dec 200710:08 amRNSGrant of Options
10th Dec 200712:56 pmRNSFurther update
7th Dec 20078:00 amRNSAdditional Listing
3rd Dec 200712:18 pmRNSProposed Directorate Changes
21st Nov 20077:30 amRNSRestoration - Transense Techn
21st Nov 20077:30 amRNSFurther Update
20th Nov 200712:14 pmRNSHolding(s) in Company
16th Nov 20073:51 pmRNSResult of EGM
16th Nov 20073:51 pmRNSSuspension - Transense Tech
16th Nov 200710:47 amRNSHolding(s) in Company
15th Nov 20077:03 amRNSGeneral Meeting update
13th Nov 20073:58 pmRNSSchedule 1 - Transense Techno

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.